TACSTD2 and lung carcinoma: A multivariable analysis also showed that high TROP2 expression was associated with longer lung cancer-specific (multivariable HR = 0.13, 95% CI = 0.020–0.44, P = 0.0003) and overall survival (multivariable HR = 0.30, 95% CI = 0.12–0.65, P = 0.0015) (Table 2).